Quantitative Systematic Strategies LLC Alnylam Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$169.75 - $207.73 $251,230 - $307,440	-1,480 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$128.63 - $176.89 $381,259 - $524,301	-2,964 Reduced 66.7%	1,480 $251,000
Q1 2021 May 06, 2021	BUY	$126.83 - $175.69 $366,285 - $507,392	2,888 Added 185.6%	4,444 $627,000
Q4 2020 Feb 09, 2021	SELL	$122.97 - $147.0 $110,795 - $132,447	-901 Reduced 36.67%	1,556 $202,000
Q3 2020 Nov 09, 2020	BUY	$121.19 - $165.49 $297,763 - $406,608	2,457 New	2,457 $358,000

Q3 2019 Nov 07, 2019	SELL	$70.9 - $87.82 $459,219 - $568,810	-6,477 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$65.86 - $92.79 $426,575 - $601,000	6,477 New	6,477 $470,000
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $480,747 - $673,826	-5,493 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$88.31 - $107.8 $485,086 - $592,145	5,493 New	5,493 $541,000

585

104M

2.82M

1.75M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.